Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Mast cells might contribute to hair loss by causing skin thickening.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Aging causes changes in the scalp that can affect hair growth and lead to older-looking hair in women.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

PCAT1 helps hair growth by controlling miR-329/Wnt10b.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

HHORSC exosomes and PL improve hair growth treatment outcomes.

Skin cell types develop when specific genes are turned on by removing certain chemical tags from DNA.

The skin's dermal layer contains true stem cells with diverse functions and interactions that need more research to fully understand.

The document concludes that a complete skin restoration biomaterial does not yet exist, and more clinical trials are needed to ensure these therapies are safe and effective.

Autologous follicular stem cells improved hair loss in 57% of patients.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.

Two microRNAs affect hair follicle development in sheep by targeting specific genes.

Hair growth-related cells need the enzyme SCD1 to help maintain the area that supports hair growth.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Skin health and repair depend on the signals between skin stem cells and their surrounding cells.

Fat under the skin can help hair grow longer, darker, and increase cell growth.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Dermal stem cells help regenerate hair follicles and heal skin wounds.

ROS may affect hair loss related to hormones.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.